Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury

Feb. 28, 2019

Targeting DEFA1/DEFA3 ameliorates sepsis severity in mice

Feb. 27, 2019

Nicotinamide N-methyltransferase inhibitor enhances aged muscle regeneration

Feb. 27, 2019

Size matters for cell prowess

Feb. 15, 2019

Making jumping genes sit still could be antiaging strategy

Feb. 14, 2019

Rho-associated protein kinase 1/2 inhibitors disclosed by Kadmon

Feb. 12, 2019

PU.1 controls yin and yang of fibrosis

Feb. 6, 2019

U.S. Department of Health & Human Services patents fatty acid derivatives

Jan. 30, 2019

Takeda Pharmaceutical divulges muscarinic M1 receptor PAMs

Jan. 11, 2019

Universite Laval patents IL-6 expression inhibitors

Jan. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...